Bittner, Stefan 
; Steffen, Falk ; Uphaus, Timo ; Muthuraman, Muthuraman ; Fleischer, Vinzenz ; Salmen, Anke ; Luessi, Felix ; Berthele, Achim ; Klotz, Luisa ; Meuth, Sven G. ; Bayas, Antonios ; Paul, Friedemann ; Hartung, Hans-Peter ; Linker, Ralf ; Heesen, Christoph ; Stangel, Martin ; Wildemann, Brigitte ; Then Bergh, Florian ; Tackenberg, Björn ; Kuempfel, Tania ; Weber, Frank ; Zettl, Uwe K. ; Ziemann, Ulf ; Tumani, Hayrettin ; Groppa, Sergiu ; Mühlau, Mark ; Lukas, Carsten ; Hemmer, Bernhard ; Wiendl, Heinz ; Gold, Ralf ; Zipp, Frauke
; Steffen, Falk ; Uphaus, Timo ; Muthuraman, Muthuraman ; Fleischer, Vinzenz ; Salmen, Anke ; Luessi, Felix ; Berthele, Achim ; Klotz, Luisa ; Meuth, Sven G. ; Bayas, Antonios ; Paul, Friedemann ; Hartung, Hans-Peter ; Linker, Ralf ; Heesen, Christoph ; Stangel, Martin ; Wildemann, Brigitte ; Then Bergh, Florian ; Tackenberg, Björn ; Kuempfel, Tania ; Weber, Frank ; Zettl, Uwe K. ; Ziemann, Ulf ; Tumani, Hayrettin ; Groppa, Sergiu ; Mühlau, Mark ; Lukas, Carsten ; Hemmer, Bernhard ; Wiendl, Heinz ; Gold, Ralf ; Zipp, Frauke 
Abstract
Background: We aim to evaluate serum neurofilament light chain (sNfL), indicating neuroaxonal damage, as a biomarker at diagnosis in a large cohort of early multiple sclerosis (MS) patients. Methods: In a multicentre prospective longitudinal observational cohort, patients with newly diagnosed relapsing-remitting MS (RRMS) or clinically isolated syndrome (CIS) were recruited between August 2010 ...
Owner only: item control page
Altmetric